GlassScriptPhysician profile
Callie Kinsley
NPI 1063801736
$794.45
in general payments reported to CMS, 2019-2025
14 companies · $251 in 2025
The $251 reported for 2025 was more than what 81% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $147 · 2022: $69.71 · 2023: $187 · 2024: $139 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $578.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $577.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $206.97 | 2021-2023 | Dyanavel Xr |
| Corium, LLC | $161.86 | 2023-2025 | Azstarys, Azstarys |
| Supernus Pharmaceuticals, INC. | $92.88 | 2023-2025 | Qelbree, Qelbree |
| Glaxosmithkline, LLC. | $56.52 | 2022-2025 | Pediarix, Rotarix, Bexsero |
| Merck Sharp & Dohme LLC | $48.71 | 2023-2024 | Vaxneuvance, Gardasil 9, M-M-R II |
| Pfizer INC. | $47.90 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $45.19 | 2025 | Jornay Pm |
| Genzyme Corporation | $27.78 | 2025 | |
| Ironshore Pharmaceuticals INC. | $22.57 | 2024 | |
| Sanofi-Aventis U.S. LLC | $17.64 | 2025 | |
| Phadia US INC. | $17.58 | 2025 | Immunocap |
| Sanofi Pasteur INC. | $17.17 | 2025 | |
| Alk-Abello, INC | $16.28 | 2023 | Grastek, Odactra, Ragwitek |
| Genentech USA, INC. | $15.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Callie Kinsley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.